Stem definition | Drug id | CAS RN |
---|---|---|
71 | 99-15-0 |
None
None
None
None
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Anticoagulation drug level above therapeutic | 75.32 | 69.12 | 14 | 377 | 1817 | 29572319 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Hepatitis acute | 67.40 | 48.92 | 18 | 752 | 13371 | 64484591 |
Anticoagulation drug level above therapeutic | 63.58 | 48.92 | 13 | 757 | 3032 | 64494930 |
Haematoma | 59.92 | 48.92 | 22 | 748 | 46228 | 64451734 |
None
Source | Code | Description |
---|---|---|
ATC | N07CA04 | NERVOUS SYSTEM OTHER NERVOUS SYSTEM DRUGS ANTIVERTIGO PREPARATIONS Antivertigo preparations |
CHEBI has role | CHEBI:25212 | metabolites |
None
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 3.9 | acidic |
pKa2 | 13.57 | acidic |
None
None
None
ID | Source |
---|---|
D07350 | KEGG_DRUG |
C0256552 | UMLSCUI |
CHEBI:166830 | CHEBI |
CHEMBL1875805 | ChEMBL_ID |
DB13226 | DRUGBANK_ID |
CHEMBL56021 | ChEMBL_ID |
70912 | PUBCHEM_CID |
5209 | INN_ID |
C088117 | MESH_SUPPLEMENTAL_RECORD_UI |
K76S41V71X | UNII |
005881 | NDDF |
735136009 | SNOMEDCT_US |
None